
Patients with depression or anxiety at the time of a diffuse large B-cell lymphoma diagnosis tended to have worse survival, recent research showed.

Patients with depression or anxiety at the time of a diffuse large B-cell lymphoma diagnosis tended to have worse survival, recent research showed.

After reflecting on my own experience and speaking to others who also had cancer, here are 12 things I’ve learned about dealing with the disease.

Supervised exercise can help to improve the immune system for patients with myeloma, recent research showed.

Being overweight might improve overall survival and progression-free survival for patients with head and neck cancer undergoing chemoradiotherapy, recent research showed.

Recent research found that patients who supplemented their vitamin D intake tended to have improved colorectal cancer outcomes.

Kim Stuck, who was diagnosed with breast cancer last year, says she "couldn’t even imagine not having cannabis during that time."

I have a confession: I daydreamed of a “last hurrah” should my cancer treatment not work.

Findings from a recent study demonstrated that exposure to Agent Orange increased the risk for bladder cancer but did not affect the disease’s aggressiveness.

Patients 65 years and older treated with Venclexta, Imbruvica and Gazyva for CLL had similar rates of progression-free survival compared with those treated with Imbruvica and Gazyva.

An expert gives an overview of the treatment options for uveal melanoma, and why he considers hope to be an essential part of the care plan.

Eating a plant-rich low-carbohydrate diet for survivors of breast cancer leads to better longevity, according to recent research.

Lymphoma treatment came with a number of unexpected side effects for me, including a runny nose.

Singer-songwriter Andrew McMahon is not the same person he was before his leukemia diagnosis, and that’s OK, he said.

Studies show that eating a high-fat meal with Alecensa can benefit patients with lung cancer throughout recovery.

There was no major difference in progression-free survival between patients with relapsed/refractory chronic lymphocytic leukemia who were treated with Calquence or Brukinsa.

I experienced unexpected rewards of decluttering.

The TILVANCE-301trial, expected to be completed in 2030, is the latest study of what has been described as one of the “phenomenal discoveries in melanoma.”

The NALIRIFOX regimen of Onivyde plus 5-fluorouracil/leucovorin and oxaliplatin has been shown to have survival and disease progression benefits for patients with pancreatic cancer in a clinical trial setting.

Factors including race, insurance and treatment history have been associated with increased cardiovascular disease, risk factors and mortality among cancer survivors, including those with a history of pediatric cancer, according to recent research.

Surviving cancer means not just checking items off a bucket list, but also taking pleasure in doing the mundane, from sweeping a porch to mowing a lawn.

From Martina Navratilova's latest cancer update to the death of the Pentagon Papers whistleblower, here's what's happening in the oncology space this week.

After two years of follow-up, patients with advanced melanoma treated with Opdivo and Opdualag continued to obtain a survival benefit compared with Opdivo alone.

The addition of Tecentriq to Cabometyx did not improve the length of time patients lived without their disease getting worse for individuals with previously treated advanced kidney cancer, and came with additional side effects, too, recent research showed.

Here are a series of poems written about our ordeal with cancer and kicking it to the curb.

After two diagnoses of acute myeloid leukemia, intense chemo and a bone marrow transplant, I’ve learned some things that helped me along the way.

Musician Andrew McMahon has made it his mission to spread the message of community and seeking mental health care like therapy for adolescents and young adults with cancer.

It is essential for patients to live a healthy lifestyle while undergoing treatment for multiple myeloma, an expert said.

The full approval is based on data showing that 80% of patients with B-ALL experienced a complete MRD response.

Most cancer memories are triggering for me, but one place is particularly sweet when I think back on it.

Adding Cabometyx to Opdivo and Yervoy tended to improve progression-free survival in patients with advanced kidney cancer, research showed.